Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NIH RECOVER: A Multi-site Pathology Study of Post-Acute Sequelae of SARS-CoV-2 Infection

NCT05292274 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05292274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05292274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NIH RECOVER: A Multi-site Pathology Study of Post-Acute Sequelae of SARS-CoV-2 Infection
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Active, not recruiting
Start date
March 30, 2022
Completion date
March 31, 2027
Enrollment
304 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars cov 2 infection